SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-308371
Filing Date
2022-12-19
Accepted
2022-12-19 16:41:06
Documents
14
Period of Report
2022-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d409932d8k.htm   iXBRL 8-K 26398
2 EX-99.1 d409932dex991.htm EX-99.1 10681
6 GRAPHIC g409932g1219182955019.jpg GRAPHIC 2176
  Complete submission text file 0001193125-22-308371.txt   175338

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ikna-20221214.xsd EX-101.SCH 2869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20221214_lab.xml EX-101.LAB 19501
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20221214_pre.xml EX-101.PRE 12169
8 EXTRACTED XBRL INSTANCE DOCUMENT d409932d8k_htm.xml XML 3654
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 221471615
SIC: 2836 Biological Products, (No Diagnostic Substances)